Phage Therapy as a Rescue Treatment for Recurrent Pseudomonas aeruginosa Bentall Infection
Abstract
:1. Introduction
2. Case Presentation
3. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Chanishvili, N. Phage Therapy—History from Twort and d’Herelle Through Soviet Experience to Current Approaches. In Advances in Virus Research; Elsevier: Amsterdam, The Netherlands, 2012; Volume 83, pp. 3–40. ISBN 978-0-12-394438-2. [Google Scholar]
- Uyttebroek, S.; Chen, B.; Onsea, J.; Ruythooren, F.; Debaveye, Y.; Devolder, D.; Spriet, I.; Depypere, M.; Wagemans, J.; Lavigne, R.; et al. Safety and Efficacy of Phage Therapy in Difficult-to-Treat Infections: A Systematic Review. Lancet Infect. Dis. 2022, 22, e208–e220. [Google Scholar] [CrossRef] [PubMed]
- Harper, D.; Parracho, H.; Walker, J.; Sharp, R.; Hughes, G.; Werthén, M.; Lehman, S.; Morales, S. Bacteriophages and Biofilms. Antibiotics 2014, 3, 270–284. [Google Scholar] [CrossRef]
- Holger, D.J.; El Ghali, A.; Bhutani, N.; Lev, K.L.; Stamper, K.; Kebriaei, R.; Kunz Coyne, A.J.; Morrisette, T.; Shah, R.; Alexander, J.; et al. Phage-Antibiotic Combinations against Multidrug-Resistant Pseudomonas Aeruginosa in in Vitro Static and Dynamic Biofilm Models. Antimicrob. Agents Chemother. 2023, 67, e0057823. [Google Scholar] [CrossRef]
- Bentall, H.; De Bono, A. A Technique for Complete Replacement of the Ascending Aorta. Thorax 1968, 23, 338–339. [Google Scholar] [CrossRef]
- Chong, J.H.; Zhang, Y.; Harky, A.; Field, M. Management and Outcomes of Proximal Aortic Graft Infection: A Systematic Review. Heart Lung Circ. 2022, 31, 49–58. [Google Scholar] [CrossRef]
- Teney, C.; Poupelin, J.-C.; Briot, T.; Le Bouar, M.; Fevre, C.; Brosset, S.; Martin, O.; Valour, F.; Roussel-Gaillard, T.; Leboucher, G.; et al. Phage Therapy in a Burn Patient Colonized with Extensively Drug-Resistant Pseudomonas Aeruginosa Responsible for Relapsing Ventilator-Associated Pneumonia and Bacteriemia. Viruses 2024, 16, 1080. [Google Scholar] [CrossRef]
- Green, S.I.; Kaelber, J.T.; Ma, L.; Trautner, B.W.; Ramig, R.F.; Maresso, A.W. Bacteriophages from ExPEC Reservoirs Kill Pandemic Multidrug-Resistant Strains of Clonal Group ST131 in Animal Models of Bacteremia. Sci. Rep. 2017, 7, 46151. [Google Scholar] [CrossRef]
- Kouijzer, I.J.E.; Baranelli, C.T.; Maat, I.; van den Heuvel, F.M.A.; Aarntzen, E.H.J.G.; Smith, T.; de Mast, Q.; Geuzebroek, G.S.C. Thoracic Aortic Vascular Graft Infection: Outcome after Conservative Treatment without Graft Removal. Eur. J. Cardiothorac. Surg. 2022, 63, ezac551. [Google Scholar] [CrossRef]
- Caradu, C.; Puges, M.; Cazanave, C.; Martin, G.; Ducasse, E.; Bérard, X.; Bicknell, C. Imperial Vascular Unit and the University Hospital of Bordeaux Vascular Unit Outcomes of Patients with Aortic Vascular Graft and Endograft Infections Initially Contra-Indicated for Complete Graft Explantation. J. Vasc. Surg. 2022, 76, 1364–1373.e3. [Google Scholar] [CrossRef]
- Ljungquist, O.; Haidl, S.; Dias, N.; Sonesson, B.; Sörelius, K.; Trägårdh, E.; Ahl, J. Conservative Management First Strategy in Aortic Vascular Graft and Endograft Infections. Eur. J. Vasc. Endovasc. Surg. 2023, 65, 896–904. [Google Scholar] [CrossRef]
- Husmann, L.; Huellner, M.W.; Ledergerber, B.; Anagnostopoulos, A.; Stolzmann, P.; Sah, B.-R.; Burger, I.A.; Rancic, Z.; Hasse, B.; the Vasgra Cohort. Comparing Diagnostic Accuracy of 18F-FDG-PET/CT, Contrast Enhanced CT and Combined Imaging in Patients with Suspected Vascular Graft Infections. Eur. J. Nucl. Med. Mol. Imaging 2019, 46, 1359–1368. [Google Scholar] [CrossRef] [PubMed]
- Fowler, V.G.; Durack, D.T.; Selton-Suty, C.; Athan, E.; Bayer, A.S.; Chamis, A.L.; Dahl, A.; DiBernardo, L.; Durante-Mangoni, E.; Duval, X.; et al. The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria. Clin. Infect. Dis. 2023, 77, 518–526. [Google Scholar] [CrossRef]
- The VASGRA Cohort Study; Husmann, L.; Ledergerber, B.; Anagnostopoulos, A.; Stolzmann, P.; Sah, B.-R.; Burger, I.A.; Pop, R.; Weber, A.; Mayer, D.; et al. The Role of FDG PET/CT in Therapy Control of Aortic Graft Infection. Eur. J. Nucl. Med. Mol. Imaging 2018, 45, 1987–1997. [Google Scholar] [CrossRef]
- Machelart, I.; Greib, C.; Wirth, G.; Camou, F.; Issa, N.; Viallard, J.F.; Pellegrin, J.L.; Lazaro, E. Graft Infection after a Bentall Procedure: A Case Series and Systematic Review of the Literature. Diagn. Microbiol. Infect. Dis. 2017, 88, 158–162. [Google Scholar] [CrossRef]
- Junghans, S.; Rojas, S.V.; Skusa, R.; Püschel, A.; Grambow, E.; Kohlen, J.; Warnke, P.; Gummert, J.; Gross, J. Bacteriophages for the Treatment of Graft Infections in Cardiovascular Medicine. Antibiotics 2021, 10, 1446. [Google Scholar] [CrossRef]
- Oechslin, F.; Piccardi, P.; Mancini, S.; Gabard, J.; Moreillon, P.; Entenza, J.M.; Resch, G.; Que, Y.-A. Synergistic Interaction Between Phage Therapy and Antibiotics Clears Pseudomonas Aeruginosa Infection in Endocarditis and Reduces Virulence. J. Infect. Dis. 2017, 215, 703–712. [Google Scholar] [CrossRef]
- El Ghali, A.; Stamper, K.; Kunz Coyne, A.J.; Holger, D.; Kebriaei, R.; Alexander, J.; Lehman, S.M.; Rybak, M.J. Ciprofloxacin in Combination with Bacteriophage Cocktails against Multi-Drug Resistant Pseudomonas Aeruginosa in Ex Vivo Simulated Endocardial Vegetation Models. Antimicrob. Agents Chemother. 2023, 67, e0072823. [Google Scholar] [CrossRef]
- Rubalskii, E.; Ruemke, S.; Salmoukas, C.; Boyle, E.C.; Warnecke, G.; Tudorache, I.; Shrestha, M.; Schmitto, J.D.; Martens, A.; Rojas, S.V.; et al. Bacteriophage Therapy for Critical Infections Related to Cardiothoracic Surgery. Antibiotics 2020, 9, 232. [Google Scholar] [CrossRef]
- Ronit, A.; Porskrog, A.; Djebara, S.; Bergmann, S.; Pirnay, J.-P.; Merabishvili, M.; Barfod, T.S.; Thomsen, K.; Brandt, C.T. Bacteriophages for the treatment of pseudomonas-infected vascular prosthesis. Ugeskr. Laeger 2024, 186, V09230617. [Google Scholar] [CrossRef]
- Blasco, L.; López-Hernández, I.; Rodríguez-Fernández, M.; Pérez-Florido, J.; Casimiro-Soriguer, C.S.; Djebara, S.; Merabishvili, M.; Pirnay, J.-P.; Rodríguez-Baño, J.; Tomás, M.; et al. Case Report: Analysis of Phage Therapy Failure in a Patient with a Pseudomonas Aeruginosa Prosthetic Vascular Graft Infection. Front. Med. 2023, 10, 1199657. [Google Scholar] [CrossRef]
- Duplessis, C.; Biswas, B.; Hanisch, B.; Perkins, M.; Henry, M.; Quinones, J.; Wolfe, D.; Estrella, L.; Hamilton, T. Refractory Pseudomonas Bacteremia in a 2-Year-Old Sterilized by Bacteriophage Therapy. J. Pediatr. Infect. Dis. Soc. 2018, 7, 253–256. [Google Scholar] [CrossRef] [PubMed]
- Chan, B.K.; Turner, P.E.; Kim, S.; Mojibian, H.R.; Elefteriades, J.A.; Narayan, D. Phage Treatment of an Aortic Graft Infected with Pseudomonas Aeruginosa. Evol. Med. Public Health 2018, 2018, 60–66. [Google Scholar] [CrossRef]
- Racenis, K.; Lacis, J.; Rezevska, D.; Mukane, L.; Vilde, A.; Putnins, I.; Djebara, S.; Merabishvili, M.; Pirnay, J.-P.; Kalnina, M.; et al. Successful Bacteriophage-Antibiotic Combination Therapy against Multidrug-Resistant Pseudomonas Aeruginosa Left Ventricular Assist Device Driveline Infection. Viruses 2023, 15, 1210. [Google Scholar] [CrossRef] [PubMed]
- Aslam, S.; Lampley, E.; Wooten, D.; Karris, M.; Benson, C.; Strathdee, S.; Schooley, R.T. Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States. Open Forum Infect. Dis. 2020, 7, ofaa389. [Google Scholar] [CrossRef] [PubMed]
- Yerushalmy, O.; Braunstein, R.; Alkalay-Oren, S.; Rimon, A.; Coppenhagn-Glazer, S.; Onallah, H.; Nir-Paz, R.; Hazan, R. Towards Standardization of Phage Susceptibility Testing: The Israeli Phage Therapy Center “Clinical Phage Microbiology”—A Pipeline Proposal. Clin. Infect. Dis. 2023, 77, S337–S351. [Google Scholar] [CrossRef]
- Suh, G.A.; Lodise, T.P.; Tamma, P.D.; Knisely, J.M.; Alexander, J.; Aslam, S.; Barton, K.D.; Bizzell, E.; Totten, K.M.C.; Campbell, J.L.; et al. Considerations for the Use of Phage Therapy in Clinical Practice. Antimicrob. Agents Chemother. 2022, 66, e0207121. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Eiferman, V.; Vion, P.-A.; Bleibtreu, A. Phage Therapy as a Rescue Treatment for Recurrent Pseudomonas aeruginosa Bentall Infection. Viruses 2025, 17, 123. https://doi.org/10.3390/v17010123
Eiferman V, Vion P-A, Bleibtreu A. Phage Therapy as a Rescue Treatment for Recurrent Pseudomonas aeruginosa Bentall Infection. Viruses. 2025; 17(1):123. https://doi.org/10.3390/v17010123
Chicago/Turabian StyleEiferman, Victor, Pierre-Adrien Vion, and Alexandre Bleibtreu. 2025. "Phage Therapy as a Rescue Treatment for Recurrent Pseudomonas aeruginosa Bentall Infection" Viruses 17, no. 1: 123. https://doi.org/10.3390/v17010123
APA StyleEiferman, V., Vion, P.-A., & Bleibtreu, A. (2025). Phage Therapy as a Rescue Treatment for Recurrent Pseudomonas aeruginosa Bentall Infection. Viruses, 17(1), 123. https://doi.org/10.3390/v17010123